Delivery Order SPE2DB22D9239-SPE2DB25FDD91

Award Date 10/16/24
Potential Completion Date 10/17/24
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $4,522.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of 4566120507 CATHFLO ACTIVASE 2 MG VIALS, a specialized pharmaceutical product, with a period of performance through October 17, 2024. This contract award is part of a larger, single-award Indefinite Delivery Contract (IDC) valued...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,380.00 firm fixed-price delivery order contract is for the supply of Cathflo Activase 2 mg vials and has an ultimate completion date of August 29, 2024. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $1,071.00 for the supply of 4564878329 CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,415.92, is to provide 4559553989 - CATHFLO ACTIVASE 2 MG VIALS to the DLA. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the agency to...
This is a firm fixed-price delivery order (SPE2DB22D9239|SPE2DB24FDK94) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,960.20 order is for CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,570.00 firm fixed-price delivery order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a period of performance through August 29, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $12,732.92, is for the delivery of ACTIVASE 50 MG VIALS medical supplies. The award is part of a larger single-award indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
This is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $1,428.00, is for the supply of CATHFLO ACTIVASE 2 MG VIALS to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price delivery order with no set-aside designation. It is part of a larger indefinite delivery contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA), specifically the Medical Supply Chain division, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,698.30 firm fixed-price delivery order is for the supply of ACTIVASE 100 MG VIALS, with a period of performance through September 5, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $31,745.75 contract is for the supply of Activase 100 mg vials, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. The award is associated with a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB25FDD91
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,768.16, covers the delivery of Cathflo Activase 2 mg vials to support the medical supply needs of military healthcare facilities.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 1/15/25, 9:01 AM